Pushing Forward With Zika Vaccines

EBioMedicine

Volumn 13, Issue , 2016, Pages 29-30

  Kennedy, Richard B ^a  

^a MAYO CLINIC   (United States)

Author keywords

Vaccine; Zika virus

Indexed keywords

UNCLASSIFIED DRUG; VIRAL PROTEIN; ZIKA E PROTEIN; ZIKA VIRUS VACCINE; SUBUNIT VACCINE; VIRUS VACCINE;

ARTHRALGIA; CONJUNCTIVITIS; DRUG EFFICACY; DRUG SAFETY; FETUS DISEASE; FEVER; HEALTH; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; NOTE; PHASE 1 CLINICAL TRIAL (TOPIC); PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RASH; VIRUS TRANSMISSION; ZIKA FEVER; ZIKA VIRUS; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MORTALITY; ZIKA VIRUS INFECTION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; VACCINES, SUBUNIT; VIRAL VACCINES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85002194671     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.10.016     Document Type: Note

References (10)

1. Abbink, P., Larocca, R.A., De La Barrera, R.A., Bricault, C.A., Moseley, E.T., Boyd, M., et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science 353:6304 (2016), 1129–1132, 10.1126/science.aah6157.
2. Barzon, L., Trevisan, M., Sinigaglia, A., Lavezzo, E., Palu, G., Zika virus: from pathogenesis to disease control. FEMS Microbiol. Lett., 363(18), 2016, 10.1093/femsle/fnw202.
3. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387:10027 (2016), 1531–1539, 10.1016/S0140-6736(16)00562-6.
4. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46:5 (1952), 509–520.
5. Dowd, K.A., DeMaso, C.R., Pelc, R.S., Speer, S.D., Smith, A.R., Goo, L., et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 16:6 (2016), 1485–1491, 10.1016/j.celrep.2016.07.049.
6. Johansson, M.A., Mier-y-Teran-Romero, L., Reefhuis, J., Gilboa, S.M., Hills, S.L., Zika and the risk of microcephaly. N. Engl. J. Med. 375:1 (2016), 1–4, 10.1056/NEJMp1605367.
7. Kim, E., Erdos, G., Huang, S., Kenniston, T., Falo, L.D. Jr., Gambotto, A., Preventative vaccines for Zika virus outbreak: preliminary evaluation. EBioMedicine 13 (2016), 315–320.
8. Larocca, R.A., Abbink, P., Peron, J.P., Zanotto, P.M., Iampietro, M.J., Badamchi-Zadeh, A., et al. Vaccine protection against Zika virus from Brazil. Nature 536:7617 (2016), 474–478, 10.1038/nature18952.
9. Thomas, S.J., L'Azou, M., Barrett, A.D., Jackson, N.A., Fast-track Zika vaccine development — is it possible?. N. Engl. J. Med. 375:13 (2016), 1212–1216, 10.1056/NEJMp1609300.
10. Tripp, R.A., Ross, T.M., Development of a Zika vaccine. Expert Review of Vaccines 15:9 (2016), 1083–1085, 10.1080/14760584.2016.1192474.